Literature DB >> 12947161

Surgical decompression of patients with large middle cerebral artery infarcts is effective.

Stefan Schwab1, Werner Hacke.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12947161     DOI: 10.1161/01.STR.0000089295.37380.A4

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Prognostic value of electroencephalography and evoked potentials in the early course of malignant middle cerebral artery infarction.

Authors:  Lothar Burghaus; Wei-Chi Liu; Christian Dohmen; Walter F Haupt; Gereon R Fink; Carsten Eggers
Journal:  Neurol Sci       Date:  2012-04-27       Impact factor: 3.307

2.  Decompressive hemicraniectomy in a 2-year-old girl with a left middle cerebral artery infarct.

Authors:  Marilyn A Tan; Aida M Salonga; Roland Dominic G Jamora
Journal:  Childs Nerv Syst       Date:  2005-11-23       Impact factor: 1.475

Review 3.  Near infrared spectroscopy: finding utility in malignant hemispheric stroke.

Authors:  Raphael Carandang; Derk W Krieger
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

4.  Evoked potentials in acute ischemic stroke within the first 24 h: possible predictor of a malignant course.

Authors:  Lothar Burghaus; Wei-Chi Liu; Christian Dohmen; Bert Bosche; Walter F Haupt
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Delayed decompressive craniectomy improves the long-term outcomes in hypertensive rats with space-occupying cerebral infarction.

Authors:  Zhan Zhao; Jian Yu; Songjie Liao; Li Xiong; Zhijian Liang; Li Ling; Fang Wang; Qinghua Hou; Wenliang Zhou; Zhong Pei; Jinsheng Zeng
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 6.  Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke.

Authors:  Eric Jüttler; Peter D Schellinger; Alfred Aschoff; Klaus Zweckberger; Andreas Unterberg; Werner Hacke
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.